The relation of ventilatory impairment and chronic mucus hypersecretion to death from all causes and death from obstructive lung disease (chronic bronchitis, emphysema and asthma) was studied in 13 756 men and women randomly selected from the general population of the City of Copenhagen. 
Abstract
The relation of ventilatory impairment and chronic mucus hypersecretion to death from all causes and death from obstructive lung disease (chronic bronchitis, emphysema and asthma) was studied in 13 756 men and women randomly selected from the general population of the City of Copenhagen. During the 10 year follow up 2288 subjects died. In 164 subjects obstructive lung disease was considered to be an underlying or a contributory cause of death (obstructive lung disease related death); in 73 subjects it was considered to be the underlying cause of death (obstructive lung disease death). Forced Some months ago Speizer et al reported in the community based "six cities" study in the United States that ventilatory impairment was the most powerful predictor of death from chronic obstructive lung disease.'9 They observed, however, that phlegm and cough were also significantly related to chronic obstructive lung disease mortality even after adjustment for the level of ventilatory function.'9 This latter finding challenges the idea that recorded symptoms of phlegm and cough are of no use in predicting death from chronic obstructive lung disease after FEV, has been taken into account.'5 17 18 The present analysis was undertaken to investigate whether the previous observations are applicable to a Scandinavian population.
We have analysed data from the Copenhagen City heart study, a large prospective epidemiological study covering more than 14 000 men and women randomly selected from the general population. The main objective was to explore whether impairment of ventilatory function and chronic mucus hypersecretion were related to mortality from chronic bronchitis, asthma, and emphysema and from all causes.
Methods

POPULATION
The Copenhagen City heart study has been described in detail.20"2 Briefly, the participants were selected from among 90 000 people living in a defined area around Rigshospitalet, the university hospital of Copenhagen. A sample of 19 698 subjects aged 20 years or more was selected at random after age stratification.
The sample fraction was highest (50%o) for those aged 40-69 years. The subjects were invited by letter to a health examination on a specific date during the period from 1 March 1976 to 31 March 1978. A total of 14 223 (740, of those invited) attended the examination.
The population sample described in the present paper comprised 13 756 subjects with the complete data required for the analysis. The subjects were followed until the end of 1987. Notification of deaths and cause of death was obtained from the central death register from the National Board of Health. In Denmark a physician, preferably the one who knew the patient best, must complete a death certificate for every death. The death certificate contains the assumed causes of deathalways the underlying cause and in many cases also a secondary and a tertiary cause. The underlying cause is defined as the disease or injury that initiated the train of events leading directly to death, whereas the secondary or tertiary cause is a disease (often As a criterion for correct performance, at least two measurements differing by less than 50o from each other had to be produced. The largest volume was used in the analysis.
Predicted values of FEV, were based on spirometric data recorded among the never smokers with a daily consumption of alcohol of less than five drinks who did not suffer from diabetes mellitus, bronchial asthma, or heart disease and had no pulmonary symptoms. The values were obtained by estimating the regression of FEV, on age and height. The estimates in ATPS were:
Women:
FEV,(ml) = 410 -27 6 x age (y) + 21 2 x height (cm) Men:
FEV,(ml) = 469 -35 2 x age (y) + 32 0 x height (cm)
Chronic mucus hypersecretion was said to be present when cough and sputum had lasted at least three months a year for more than one year. All subjects reported whether they were current smokers, ex-smokers, or never smokers and the duration of smoking. Ex-smokers were defined as former smokers who had stopped smoking more than one year before the examination. Current smokers reported their daily tobacco consumption and the type of tobacco smoked, and whether they inhaled. The total amount of tobacco smoked per day was calculated on the basis of the following equivalents: one plain or filter cigarette = 1 g; one cigar = 5 g; one cheroot or cigarillo = 3 g; one g of pipe tobacco = 1 g. An estimate of lifetime tobacco consumption was calculated as pack years (current tobacco consumption (g/day) x duration of smoking (y)/20). As an indicator of socioeconomic status we used the reported duration of school education. Body mass index was calculated as weight/height2 (kg/m2). Alcohol consumption was reported in the questionnaire as the number of drinks per day. The subjects were classified as having heart disease if they reported previous myocardial infarction or current use of heart medication in the questionnaire. Diabetes mellitus and bronchial asthma were registered when subjects gave positive answers to the relevant items in the questionnaire.
STATISTICAL ANALYSIS
The analysis is concerned with total mortality, obstructive lung disease related mortality, and obstructive lung disease mortality. We used the Cox proportional hazards model. CI-9500 confidence interval. with age, lung function impairment, chronic mucus hypersecretion, smoking, and alcohol consumption. Mortality was higher in men than women and in subjects with bronchial asthma, diabetes mellitus, and heart disease than in those without these conditions. Subjects with a body mass index of 20-29 kg/ m2 had a slightly lower unadjusted mortality than those with both lower and higher values. Similar trends were observed with regard to obstructive lung disease related mortality and obstructive lung disease mortality except for the lack of an association between diabetes and heart disease and death and the fact that both obstructive lung disease related and obstructive lung disease deaths were more common in subjects in the lowest body mass index category (table 2) .
Estimated relative risks for obstructive lung disease related mortality are given in table 3. In neither sex was the presence or absence of heart disease or diabetes, alcohol consumption, or the length of school education significantly related to mortality. The risk increased with decreasing FEVy1% pred and body mass index, with increasing age, and with the presence of bronchial asthma. Chronic mucus hypersecretion was significantly associated with obstructive lung disease death in men only, whereas lifetime tobacco consumption was related to mortality only in women.
The analysis of the obstructive lung disease mortality is shown in table 4. Among women there were no deaths from obstructive lung disease among the non-inhalers or those with the highest body mass indices. The grouping according to smoking habits and body mass index was therefore slightly modified. In both sexes FEVy1% pred and presence or absence of chronic mucus hypersecretion were significantly related to mortality. The analysis of first order interaction terms showed a significant interaction (p = 002) between the effects of FEV, and chronic mucus hypersecretion on obstructive lung disease mortality. This interaction indicates that chronic mucus hypersecretion was associated with only a slightly increased risk of obstructive lung disease death in subjects with a high FEV1% pred, while the risk increased substantially with low values. The figure illustrates this interaction by showing the estimated relative risks for obstructive lung disease mortality obtained from a regression model with FEV1% pred as a continuous variable. The remaining independent variables were the same as in table 4. The plot of relative risks for subjects with and without chronic mucus hypersecretion indicates that the relative effect ofchronic mucus hypersecretion on obstructive lung disease mortality is small among subjects with a high FEV1% pred (for an FEV1% pred of 80 the RR is 1-2), but much higher among subjects with a low FEV1% pred (for an FEV1 % pred of40 the RR is 4-2). tion; yet it is believed to predispose to airway infections.'628 In a recent prospective study egression analysis of total Vestbo et al found a significant relation bettable 6. The association ween mucus hypersecretion and admission to t with deaths from all hospital on account of chronic obstructive lung ificant for both sexes, but disease after including FEV, in the analysis.29 association with obstruc-As airway infection in patients with impaired ted and obstructive lung lung function is the most common precipitatlic mucus hypersecretion ing cause of fatal respiratory failure, and as ociated with deaths from most deaths from chronic obstructive lung n, the relative risk being disease take place in hospital, it is surprising at for obstructive lung that no significant link between chronic mucus duration of smoking and hypersecretion and death from respiratory dis--ase or diabetes, a very ease and specifically chronic obstructive lung ly mass index, and both disease has been reported in the two previous ohol and a high alcohol population studies. ' (n)) (rate (n)). There are several possibilities for explaining (7) 3 (3) the discrepancies between our findings and the (9) 102 (4) results of the two previous British studies. 10) 79 (13) Firstly, our study is community based and (6) 310 (21) differs from the previous ones with regard to 
